Newsom signs ban on ‘pay-to-delay’ deals for drug makers
Gov. Gavin Newsom signed a bill designed to thwart so-called pay-to-delay settlements between drug makers.
AB 824 addresses a phenomena that grew out of the Hatch-Waxman Act, a 1984 federal law intended to lower drug prices. That law created a 180-day exclusivity window for the first company to file to sell a generic version of drug once a p...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In